Ispire Technology Inc. Q3 FY2025 earnings call

• Reduced accounts receivable by approximately $7.3 million to $60.4 million during the quarter by implementing strict payment and collection policies.
• Secured interim nicotine product manufacturing license in Malaysia, with plans to have 80 production lines and anticipate final license in coming months.
• IKE Tech LLC filed component PMTA for blockchain-based point of use age-gating system with FDA, with potential modular use in ENDS products.
• Preparing to file pod system and disposable vape PMTAs incorporating IKE Tech's age-gating system, planning to introduce flavored products.
• Launched Sprout cannabis vapor device in partnership with Raw Garden, designed for purity, performance, and safety.
• Shifted pricing strategy from landed pricing to FOB factory pricing to enhance flexibility and market position.

For the third quarter of fiscal 2025, total revenue was $26.2 million, down from $30 million in the same period last year. European revenues were approximately $13.2 million, representing a slight decline of $0.3 million or 2.9% compared to the same period in fiscal 2024. Revenue from North America was approximately $8.8 million, a decline of $3.6 million or 28.9% compared to fiscal 2024. Asia Pacific revenues were $3 million, a decline of $0.8 million or 21.4% compared to fiscal 2024. Africa revenues were $0.1 million, roughly flat. Gross profit for Q3 was approximately $4.8 million compared to $6.1 million in fiscal 2024, with gross margins at 18.2% down from 20.4% last year.

• Expect to continue reducing accounts receivable by focusing on higher quality and larger customers with improved payment terms.
• Anticipate receiving final nicotine manufacturing license in Malaysia.
• Optimistic about IKE Tech's PMTA approval and its potential to revolutionize ENDS devices globally.
• Plan to introduce flavored products with age-gating system if PMTA approved, providing adult consumers with safe-regulated alternatives.

• Impact of tariffs on Chinese-made goods affecting product pricing dynamics and margins.
• Geopolitical factors posing risks to manufacturing and supply chain stability.
• Regulatory uncertainties related to FDA approvals for PMTAs.
• Potential impact of accounts receivable levels on cash flow and financial stability.

Q: Just on the FDA and the focus on port shopping. Help us understand what that could mean regarding the illicit vape supply in the U.S. and if it could reduce illicit product flow and change growth opportunity in North America near-term.

A: With IKE Tech's age-gating technology, we believe it can convert consumers from black-market to legal products. The black market for vaping products is large, and this technology could convert a significant portion. Near-term, U.S. revenue from such products may be limited, but opportunities exist outside the U.S.

Q: On the EU and disposable vape bans. Are there any countries in particular you're looking at and are there supply constraints?

A: EU countries like the UK are banning disposables, and we expect to benefit. Our Malaysian facility with 80 production lines has capacity to support demand, whether for our own products or others.

Q: On cannabis customer reactions and tariffs. Talk about customer reactions to new hardware and alternatives for customers regarding tariffs.

A: Customers have reacted positively to products like Sprout and Volt platform. Tariffs have affected U.S. cannabis revenue, but we've renegotiated contracts to FOB factory pricing, and Malaysia offers lower tariff advantages over competitors' manufacturing locations.